← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP and Chief Compliance Officer Indrani Lall Franchini sold $786K of Alexion Pharmaceuticals, Inc.

Sold$785,981
$114.69Price
6,853Shares
−20%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Mon, Jun 8. Filed Tue, Jun 9, 1:05 PM ET, during the session. Not investment advice.